Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
Status:
Not yet recruiting
Trial end date:
2022-02-26
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the effect of continuation of buprenorphine/naloxone in
patients with history of Opioid Use Disorder (OUD) scheduled for surgery compared to reduced
dose buprenorphine/naloxone prior to surgery on pain scores, opioid consumption, depressive
symptoms and severity of substance use dependence- including record of problematic use of any
non-prescribed opioids, alcohol and illicit narcotics.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone